Get started
OPKO Health, Inc.OPKO Health, Inc.OPKO Health, Inc.

OPKO Health, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonalsBonds

0KCS trade ideas

OPKO Health | OPK | Long at $1.12OPKO Health finally closed the price gap on the daily chart between $1.11 and $1.12. There are no more price gaps below the current price (bullish). In the past year, insiders (primarily the CEO), have purchased over $4.7 million of shares at an average price of $1.55. Historically, this stock is very cyclical, and I believe we are near the bottom before the next cycle up. I have no idea when this will occur (may trade sideways for a while or dip below $1 in the near-term), but the insider purchases tell me they are preparing for a move. Average analyst price targets are between $2.75 and $3.99 right now, depending on the source. Book value = $1.66. As with any biopharmaceutical and diagnostics company, NASDAQ:OPK is purely speculative at this stage - yet raking in over $600 million in annual revenue. My personal buy for NASDAQ:OPK was triggered at $1.12 and I hope to see more insider buying at this level. Targets into 2028: $1.40 (+22.8%) $1.66 (+45.6%) Squeeze for any reason = $5.00 (+338.6%)
NASDAQ:OPKLong
by WorthlessViews
OPK Longin uptrend, trendline break + retest Long 1.6 Stop 1.35 Target 2.2 Risk management is much more important than a good entry point. I am not a PRO trader. In my trading plan, the Max Risk of each short term trade should be less than 1% of an account. For non-Pro option traders, better begin from buying ITM options and keep 90+ days, Selling OTM and less than 60 days. I will try some samples to test my chart reading and OP strategy : "Buy in the money (ITM) calls in daily uptrend, and keep 400 days. " CAN price 1.6 11/19/2024 BuyToOpen Jan2026 Call C1 Limit 1.0 (C1 Delta 0.87 , 422 days ) ITM C1 has 0.6 value. OPK price 1.6 11/20/2024 BuyToOpen Jan2026 Call C1 Limit 0.65 (C1 Delta 0.85 , 421 days ) ITM C1 has 0.6 value.
NASDAQ:OPKLong
by PlanTradePlanMM
OPK - potential biotech gap playOPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals. This is not a financial advice! Short Float 30.23% Rel. Vol. on 03/25/24 at 2.09 - it's been slowling increasing recently Lots of block buys and insider buys. It's more of a slower play IMO. We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work. We need to break and stay above 1.10 before executing a trade. Multi - Resistance level arround 1.2-1.3! Needs to get broken for a further upmove. SL under 0.9 TP approx. 1.5 (gap fill) or 2.15 Most info on the chart. Trade carefully!
NASDAQ:OPKLong
by meitshels_smell_trades
Is OPK Fibbin'?OPK back at the .236 fib line, which has been a clear area of support/resistance. The question is, will the speculation on its testing company end up giving the boost needed to push back above the $5 mark or is this truly a "fib" and OPK falls back down heading into the rest of March? "Ongoing pressure from an activist investor to offload its BioReference unit has also become a source of speculation. This stemmed from recent M&A action within the diagnostics space earlier this month. Needless to say, the recent action in the stock has continued supporting some analysts’ bullish stances on the company. Most recently, Barrington Research boosted its price target to $8 from $7 and maintained its Outperform rating." Quote Source: Best Penny Stocks On Robinhood To Watch This Week If You Like Biotech
NASDAQ:OPK
by PennyStocks101
$OPK Prime for a squeeze or RejectionLooking at the daily chart, $OPK looks prime for squeeze to 7.21$ and then 8.92$. The good: - ascending triangle - Bullish MACD - Positive momentum - COVID-19 test positive upside (recent agreement with daily test for NBA players) The Bad: - RSI rising - BIG resistance at 6.10-6.30 - triple top if does not break through downside could be big Lastly, we cannot forget to mentioning the shorts. Due to the recent development with $GME, shorts could be a HUGE catalyst for this stock. I did not include it however, as I do not have any details on the shorts position and/or any idea if the new stream of retail investors could have a miningful impact of the stock, as they seems to be focusing more on $GME, $AMC, $BBY, $NOK, etc...
NASDAQ:OPKLong
by aristocks